A major advance in cancer study is occurring with the use of nanobodies to reactivate dysfunctional p53. This crucial cancer suppressor protein is frequently disabled in various forms of malignancies, resulting https://baidubookmark.com/story21776609/mini-antibodies-reactivate-tumor-suppressor-p53-new-potential-approach-for-cancer-therapy